Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Revista Brasileira De Ginecologia E Obstetricia : Revista Da Federacao Brasileira Das Sociedades De Ginecologia E Obstetricia|June 27, 2022
Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic NeoplasiaLuz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
American Journal of Obstetrics and Gynecology|May 15, 2019
A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcomeBeryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 27, 2013
Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancerJose Alejandro Rauh-Hain, Stephanie H Guseh, Katharine M Esselen, et al.
Gynecologic Oncology|June 24, 2018
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
Gynecologic Oncology|July 10, 2021
Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancerCarolyn N Krasner, Susana M Campos, Chantay L Young, et al.
Annals of Surgical Oncology|March 8, 2021
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian CancerBeryl L Manning-Geist, Mackenzie W Sullivan, Vishnudas Sarda, et al.
Clinics (Sao Paulo, Brazil)|July 31, 2023
Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian casesAntonio Braga, Elaine Balthar, Laís Cristhine Santos Souza, et al.
Gynecologic Oncology|March 13, 2019
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?Paulo Alexandre Ribeiro Mora, Sue Yazaki Sun, Guillermo Coca Velarde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 12, 2016
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CAJaclyn C Watkins, Brooke E Howitt, Neil S Horowitz, et al.
Pageof 15